Publications SMA18-5063PT3
Print This Page Bookmark and Share
TIP 63: Medications for Opioid Use Disorder –  Pharmacotherapy for Opioid Use Disorder (Part 3 of 5)

TIP 63: Medications for Opioid Use Disorder – Pharmacotherapy for Opioid Use Disorder (Part 3 of 5)

Add To Favorites

Guidelines or Manual - Out Of Stock

Download Digital Version

Average Rating: 5 out of 1 ratings.
Price: FREE (shipping charges may apply)

Standard shipping is free. Expedited delivery has associated costs. You will be able to review shipping options and costs during check-out.

Part 3 of this Treatment Improvement Protocol (TIP) describes general principles of opioid use disorder (OUD) pharmacotherapy and discusses medication formulations, indications, and dosing for the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine. Part 3 also discusses patient management and monitoring in outpatient settings other than opioid treatment programs (OTPs) as well as medical management of patients with OUD in hospital settings.

Pub id: SMA18-5063PT3
Publication Date: 2/2018
Last Reviewed: 02/12/2018
Popularity: 51
Format: Guidelines or Manual
Audience: Professional Care Providers
Series: TIP 63: Medications for Opioid Use Disorders
Population Group: People with Substance Use or Abuse Problems as Population Group

You May Also Be Interested In

Write a Comment

Fields marked with an * are required.


For any questions regarding product availability or ordering methods, please review our Help Page . To be considered for public posting, comments should be geared towards helping visitors assess the quality of this content, and must adhere to the HHS Comment Policy.

Type the case-sensitive characters you see in the picture below.

Customer Comments